RxAll

RxAll

Private
New Haven, ConnecticutHealthcare & Life Scienceshttps://rxall.net

Last Round

Seed

Jul 20, 2021

Total Funding Raised

$2.66M

Momentum Score

25 /100

Company Overview

RxAll is a healthcare technology company that provides a digital infrastructure platform for authenticating drugs and enabling on-demand access to medicines for hospitals, pharmacies, and patients.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, Medical Devices, Point-of-Sale, Lending & Credit

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Subscription SaaS, Payment Processing Fee, Government Contracts, Data as a Service, Marketplace Commission

AI Layer

Application

Keywords

drug authenticationcounterfeit drug detectionB2B pharma marketplaceRxScannerhandheld drug scannerdrug quality assuranceAI spectroscopypharmaceutical supply chainPharmaTechsupply chain integritypharmacy management softwarepharmacy POSpharmacy financinginvoice financingHealthTechspectral database

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RxAll Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

RxAll Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedJul 20, 2021
AcceleratorSep 21, 2020
GrantMar 21, 2019

RxAll Investors

Notable investors and investment history

InvestorRounds
Standard Bank GroupAccelerator
Founders Factory AfricaAccelerator
Hello TomorrowGrant
SOSVSeed
BNP ParibasGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 10, 2025

    Named an honoree in Fast Company's 2025 World Changing Ideas Awards.

RxAll Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

RxAll Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about RxAll's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew Haven, Connecticut
Employee Range22
Year Founded2016
Last FundingJul 20, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.